The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier
Open accessAbstract
Significance: Drug delivery to the brain is a challenging and elusive goal. Conjugating with ligands of target molecules including transferrin receptor modestly enhances cerebral accumulation of drugs and drug carriers. We found that conjugating with ligands of VCAM-1 provides order(s) of magnitude higher cerebral accumulation of nanocarriers, especially in the inflamed brain. VCAM-1 targeted nanocarriers loaded with messenger RNA encoding endothelial glycoprotein thrombomodulin cause expression of the transgene in the lumen of cerebral vasculature. This alleviates pathological permeability of the blood–brain barrier in mouse model of neurovascular inflammation. These results provide a basis for precise and effective molecular interventions in the cerebral vasculature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312 · cited 2×
“Early BBB permeability has been identified as a key therapeutic target in a variety of brain injuries (20, 39).”
BackgroundThe glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075
Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014
Self-citationMacrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.011 · Cited by 607
Montagne, A., Gauberti, M., Macrez, R., Jullienne, A., Briens, A., Raynaud, J.-S., Louin, G., Buisson, A., Haelewyn, B., Docagne, F., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.018 · Cited by 70
Cited by
Nanomaterial Delivery Systems for mRNA Vaccines
Buschmann, M. D., Carrasco, M. J., Alishetty, S., Paige, M., Alameh, M. G., & Weissman, D. (2021) · Vaccines · doi:10.3390/vaccines9010065 · Cited by 582
Self-citationDrug delivery to the central nervous system
Nance, E., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 414
Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Parhiz, H., Atochina-Vasserman, E. N., & Weissman, D. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02444-3 · Cited by 279
Self-citationRecent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
Su, S., & M. Kang, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090837 · Cited by 259
Metadata
- Authors
- Marcos-Contreras, O. A., Greineder, C. F., Kiseleva, R. Y., Parhiz, H., Walsh, L. R., Zuluaga-Ramirez, V., Myerson, J. W., Hood, E. D., Villa, C. H., Tombacz, I., Pardi, N., Seliga, A., Mui, B. L., Tam, Y. K., Glassman, P. M., Shuvaev, V. V., Nong, J., Brenner, J. S., Khoshnejad, M., Madden, T., Weissmann, D., Persidsky, Y., & Muzykantov, V. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2020-01-31
- Volume
- 117
- Issue
- 7
- Pages
- 3405-3414
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3003353139
- Cited by
- 185
- References
- 5
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier. https://app.cochat.ai/papers/10.1073/pnas.1912012117
- The paper
- Marcos-Contreras, O. A., Greineder, C. F., Kiseleva, R. Y., Parhiz, H., Walsh, L. R., Zuluaga-Ramirez, V., Myerson, J. W., Hood, E. D., Villa, C. H., Tombacz, I., Pardi, N., Seliga, A., Mui, B. L., Tam, Y. K., Glassman, P. M., Shuvaev, V. V., Nong, J., Brenner, J. S., Khoshnejad, M., . . . Muzykantov, V. R. (2020). Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1912012117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.